<!--
title: diffeqdrugs
description: 
published: 1
date: 2021-02-22T12:38:16.738Z
tags: 
editor: ckeditor
dateCreated: 2021-02-22T12:16:34.770Z
-->

<ul>
  <li><a href="#modelling-drug-concentrations">Modelling Drug Concentrations</a>
    <ul>
      <li><a href="#worked-example">Worked Example</a>
        <ul>
          <li><a href="#section-11.2-question-2">Section 11.2, Question 2</a></li>
          <li><a href="#section-11.2-question-3">Section 11.2, Question 3</a></li>
          <li><a href="#section-11.2-question-5">Section 11.2, Question 5</a></li>
          <li><a href="#next-question-like-7-i-think">next question like 7 I think</a></li>
        </ul>
      </li>
    </ul>
  </li>
</ul>
<h1>Modelling Drug Concentrations</h1>
<h2>Worked Example</h2>
<h3>Section 11.2, Question 2</h3>
<p>If \(k = 0.05 \text{ hr}^{-1}\) and the highest safe concentration is \(e\) times the lowest effective concentration, find the length of the time between repeated doses that will ensure safe but effective concentrations.</p>
<h4>Solve the Decay Model</h4>
<p>let:</p>
<figure class="table" style="width:80%;">
  <table>
    <tbody>
      <tr>
        <td style="text-align:center;">\(t\)</td>
        <td>be the time (variable) since the last dose was administered</td>
      </tr>
      <tr>
        <td style="text-align:center;">\(T\)</td>
        <td>be the constant time between doses</td>
      </tr>
      <tr>
        <td style="text-align:center;">\(c_n\left( t \right)\)</td>
        <td>be the blood concentration, after a period of \(t\), following the \(n\)th dose</td>
      </tr>
      <tr>
        <td style="text-align:center;">\(c_0\)</td>
        <td>be the initial dose administered, which will also be the constant dosage and initial blood concentration at \(t= 0\)</td>
      </tr>
      <tr>
        <td style="text-align:center;">\(H= r\cdot L,\)</td>
        <td>be the maximum safe dosage, \(\quad \exists ! r \in \mathbb{R^+}\)&nbsp;</td>
      </tr>
      <tr>
        <td style="text-align:center;">\(L\)</td>
        <td>be the minimum effective dosage</td>
      </tr>
      <tr>
        <td style="text-align:center;">\(C_n\)</td>
        <td>be the drug level immediately following administration</td>
      </tr>
      <tr>
        <td style="text-align:center;">$R_n$</td>
        <td>be the drug level remainining immediately preceeding administration.</td>
      </tr>
    </tbody>
  </table>
</figure>
<p>&nbsp;<br>Presume that the rate of drug metabolism is proportional to the drug levels \(c\left( t \right)\):</p>
<p>\[\begin{aligned} \frac{\operatorname{d}c }{\operatorname{d} t} &amp;\propto c\left( t \right) \\ \ln{ \left| c\left( t \right) \right| } &amp;= -kt+ \lambda, \quad \exists \lambda \in \mathbb{R}\end{aligned}\]</p>
<p>blood levels will be positive and so the absolute value may be dispenced with:</p>
<p>\[\begin{aligned} \ln{ \left( c\left( t \right) \right) } &amp;= -kt + \kappa \notag\\ \implies c\left( t \right) &amp;= \lambda^*\cdot e^{-kt}, \quad \exists \lambda^* \in \mathbb{R}\end{aligned}\]</p>
<p>Applying the initial condition that \(c\left( 0 \right)= c_0\):</p>
<p>\[\begin{aligned} c\left( 0 \right)= c_0 &amp;= \lambda^*\cdot e^{-k0} \notag \\ \implies \lambda^* &amp;= c_0 \end{aligned}\]</p>
<p>Hence the blood concentration levels, as a function of time will be:</p>
<p>\[\begin{aligned} c\left( t \right)&amp;= c_0\cdot e^{-kt} \end{aligned}\]</p>
<h4>Solve the Time between doses</h4>
<p>Presume when a dose is applied that the level instantaneously reaches the higher level as shown in the diagram at .</p>
<p>The blood concentration will not necessarily reach the overdose threshold \(H\) or the minimum effective threshold \(L\) following the first dose, as shown in the figure at , there will however be a maximum \(\left( t_{\textit{max}}, c_\textit{max} \right)\) and a minimum concentration \(\left( t_{\textit{min}}, c_{\textit{min}} \right)\):</p>
<p>\[\begin{aligned} c&amp;= c_0e^{-kt}\notag \\ e^{-kt} &amp;= \frac{c}{c_0}\notag \\ -kt &amp;= \ln{ \left( \frac{c}{c_0} \right)}\notag \\ t &amp;= \frac{1}{-k} \cdot \ln{ \left( \frac{c}{c_0} \right)}\notag \\ \end{aligned}\]</p>
<p>The time between dosages, if the dosages are constant, must be the difference between the maximum concentration and the minimum concentration, if the minimum concentration is limited by the effective minimum dosage \(L\) and the maximum effective dosage is limited by the safe threshod \(H= r\cdot L\) then we have:</p>
<p>\[\begin{aligned} T &amp;= t\left( c_{\text{max}} \right) - t\left( c_{\text{min}} \right)\notag \\ &amp;= \frac{1}{-k}\left[ \ln{ \left( \frac{c_{\text{max}}}{c_0} \right) - \ln{ \left( \frac{c_{\text{min}}}{c_0} \right) } } \right]\notag \\ &amp;= \frac{1}{-k}\left[ \ln{ \left( \frac{L\cdot r}{c_0} \right) - \ln{ \left( \frac{L}{c_0} \right) } } \right]\notag \\ &amp;= \frac{1}{-k}\cdot \ln{ \left( r \right) } \label{eq:T Defininition}\end{aligned}\]</p>
<p>Thus the time between repeated doses must be less than \(T\), where \(T\) is defined as above at .</p>
<h4>What is the size of the dose</h4>
<p>It is not possible to determine the size of each dose, we would need to know the upper/lower limits or, in this case, \(r\).</p>
<h3>Section 11.2, Question 3</h3>
<p>Suppose \(k = 0.05 \text{ hr}^{- 1}\) and \(T = 10 \text{ hr}\); what is the smallest \(n\) such that \(R_n&gt;0.5\cdot R\)</p>
<h4>Solve the Decay Function</h4>
<p>\[\begin{aligned} \frac{\operatorname{d}C }{\operatorname{d} t} \propto C\notag \\ \implies \frac{1}{C}\cdot \frac{\operatorname{d}C }{\operatorname{d} t}&amp;= -k, \quad \exists k\in \mathbb{R}^{- } \notag \\ \implies \ln{ \left| C \right| }&amp;= -k\cdot t+ \lambda, \quad \exists \lambda \in \mathbb{R}\notag \\ \implies C\left( t \right)&amp;= \lambda^*\cdot e^{-k\cdot t}, \quad \exists \lambda^* \in \mathbb{R}\end{aligned}\]</p>
<p>Now by using the initial condition that \(C\left( 0 \right)= C_0\): \[\begin{aligned} C\left( 0 \right)&amp;= \lambda^*\cdot e^{0} \notag \\ \implies \lambda^* &amp;= C_0 \notag \\ \implies C\left( t \right)&amp;= C_0\cdot e^{-k\cdot t} \end{aligned}\]</p>
<h4>Solve the levles for repeated doses</h4>
<p>The function \(C_n\left( t \right)\) that describes drug levels, given the simplifying assumption that drug levels immediately rise following administration of the drug, is described by a sequence of seperate functions, \(\left( C_1\left( t \right), C_2\left( t \right), C_3\left( t \right) \dots C_n\left( t \right) \right)\) corresponding to the domain \(\left( \left( n- 1 \right)\cdot T , T \right)\) respectively.</p>
<h5>Solve the value of \(C_n\)</h5>
<p>Following the initial dose of \(C_0\), a subsequent dose will need to be administered after a period of time \(T\), which correspoonds to the constant dosing schedule, at this time the blood levels will be:</p>
<p>\[\begin{aligned} R_1&amp;= C\left( T \right) \\ &amp;= C_0\cdot e^{-k\cdot t}\end{aligned}\]</p>
<p>At this time, the simplifying assumption is made that the levels rise immediately to reach \(C_2\), which is given by the initial value pluse the dose \(C_0\) (which is also assumed constant):</p>
<p>\[\begin{aligned} C_1&amp;= C_0+ R_1 \notag \\ &amp;= C_0+ C_0\cdot e^{-k\cdot t}\end{aligned}\]</p>
<p>Following this the levles will again decrease up until the time of the next dose, after a period of \(t= T\), but this time they will fall from an initial value of \(C_1\):</p>
<p>\[\begin{aligned} R_2&amp;= C_1\cdot e^{- kT}\notag \\ &amp;= \left( C_0 + C_0\cdot e^{- kT} \right)\cdot e^{- kT}\notag \\ &amp;= C_0e^{- kT} + C_0\cdot e^{- 2kT}\end{aligned}\]</p>
<p>following the preceeding logic:</p>
<p>\[\begin{aligned} C_2 &amp;= R_2 + C_0 \notag \\ &amp;= C_0 + C_0 \cdot e^{- kT} + C_0 \cdot e^{- 2kT}\end{aligned}\]</p>
<p>now by the geometric series we have \(\sum^{n- 1}_{i= 0} \left[ r^n \right]= \frac{1- r^n}{1- r}\) so:</p>
<p>\[\begin{aligned} R_3 &amp;= C_2 \cdot e^{- kT}\notag \\ &amp;= \left( C_0 po C_0 \cdot e^{- kT} + C_0 \cdot e^{- 2kT} \right) \cdot e^{- kT}\notag \\ &amp;= c)e^{- kT} + C_0 e^{- 2kT} + C_0 e^{- 3kT}\notag \\ \dots \notag \\ R_n &amp;= C_0\cdot \sum^{n}_{i= 1} \left[ \left( e^{- kT} \right)^i \right] \notag\\ &amp;= \frac{C_0\cdot e^{- kT} \cdot \left( 1- e^{- kTn} \right)}{\left( 1- e^{- kT} \right)}\end{aligned}\]</p>
<p>The long term behaviour of the concentration levels will be:</p>
<p>\[\begin{aligned} R= R_{\infty} &amp;= \lim_{n \rightarrow \infty}\left[ R_n \right]\notag \\ &amp;= \lim_{n \rightarrow \infty}\left[ \frac{C_0 - e^{- kTn}}{\left( e^{- kT} - 1\right)} \right]\notag \\ &amp;= \frac{C_0 - \lim_{n \rightarrow \infty}\left[ e^{- kTn} \right]}{\left( e^{- kT} - 1\right)} \notag\\ &amp;= \frac{C_0 - 0}{\left( e^{- kT} - 1\right)} \notag \\ &amp;= \frac{C_0 }{\left( e^{- kT} - 1\right)} \end{aligned}\]</p>
<p>The concentration level is hence given by:</p>
<p>\[\begin{aligned} C_n &amp;= C_0+R_n \notag \\ &amp;= c_0 + 1 + \frac{1 - e^{- kTn}}{\left( e^{- kT} - 1 \right)} \notag\\ c_\infty &amp;= \lim_{n \rightarrow \infty}\left[ C_n\left( t \right) \right] \notag\\ &amp;= C_0 + R_\infty \notag\\ &amp;= c_0\left( 1 + \frac{1}{\left( e^{- kT} - 1 \right)} \right) \notag\\\end{aligned}\]</p>
<h4>Substitute the Dose Schedule</h4>
<p>From above we have that the dose schedule is:</p>
<p>\[\begin{aligned} T&amp;= \ln{ \left( r \right) }\cdot \frac{1}{k} \notag\end{aligned}\]</p>
<p>hence by substitution:</p>
<p>\[\begin{aligned} 10 = 100\cdot \ln{ \left( r \right) } \\ r= e^{\frac{1}{10}}\end{aligned}\]</p>
<p>Hence we may conclude: \[\begin{aligned} H= e^{\frac{1}{10}}\end{aligned}\]</p>
<p>Now in order to solve \(n\) :</p>
<p>\[\begin{aligned} r_n &amp;&gt; 0.5\cdot R \\ \frac{C_0 \cdot e^{- kT}\left( 1- e^{- kTn} \right)}{1- e^{- kt}} &amp;&gt; \frac{C_0}{2\left( e^{kt} - 1 \right)} \notag \\ \end{aligned}\]</p>
<p>multiply the RHS by \(\frac{e^{- kt}}{e^{- kt}}\)</p>
<p>\[\begin{aligned} \frac{C_0 \cdot e^{- kT}\left( 1- e^{- kTn} \right)}{1- e^{- kt}} &amp;&gt; \frac{C_0\cdot e^{- kt}}{2\left(1- e^{-kt} \right)} \notag \\ \end{aligned}\]</p>
<p>because \(\left( 1- e^{- kt} \right)&gt;1\):</p>
<p>\[\begin{aligned} C_0\cdot e^{- kT}\left( 1- e^{- kTn} \right) &amp;&gt; C_0\cdot e^{- kT} \cdot \frac{1}{2}\notag \\ 1- e^{- kTn}&amp;&gt;\frac{1}{2} \notag \\ \frac{1}{2}&amp;&gt;e^{- kTn} \notag \\ -\ln{ \left( 2 \right) } &amp;&gt; - kTn\notag \\ \ln{ \left( 2 \right) }&amp;&lt;kTn\notag \\ \frac{\ln{ \left( 2 \right) }}{kT} &amp;&lt; n\notag \\ n&amp;&gt;\frac{\ln{ \left( 2 \right) }}{kT}\notag \\ n&amp;&gt;10\times \ln{ \left( 2 \right) } \notag \\ n&amp;&gt;6.9\end{aligned}\]</p>
<p>\(\therefore\) \(n = 7\) is the minimum value of \(n\) that satisfies that condition.</p>
<h3>Section 11.2, Question 5</h3>
<p>Suppose that \(k= 0.2 \text{ hr}^{- 1}\) and that the smallest concetration is 0.03 mg/ml. A signle dose that produces a concentration of 0.1 mg/ml is administered. Approximately how many hours will the drug remain effective?</p>
<p>From the previous working we have:</p>
<p>\[\begin{aligned} \frac{\operatorname{d}C }{\operatorname{d} t}= C\left( t \right) \implies C\left( t \right)= C_0\cdot e^{k\cdot t}\end{aligned}\]</p>
<p>and the question provides:</p>
<p>\[\begin{aligned} C_0&amp;= 0.1\\ L&amp;= 0.03\end{aligned}\]</p>
<p>Now substitute the values and find \(t\) :</p>
<p>\[\begin{aligned} L&amp;= C\left( t \right)\\ &amp;= C_0\cdot e^{k\cdot t}\notag \\ kt&amp;= \ln{ \left( \frac{C_0}{L} \right) }\\ t&amp;= \frac{1}{k}\cdot \ln{ \left( \frac{C_0}{L} \right) }\notag \\ &amp;= 5\cdot \ln{ \left( \frac{10}{3} \right) }\notag \\ &amp;= 6 \text{ hours, } 1 \text{ min }\end{aligned}\]</p>
<p>\(\therefore\) the dosage will be effective for only six hours</p>
<h3>next question like 7 I think</h3>
<p>"text/css" /*! normalize.css v2.1.3 | MIT License | git.io/normalize */ /* ========================================================================== HTML5 display definitions ========================================================================== */ /** * Correct `block` display not defined in IE 8/9. */ article, aside, details, figcaption, figure, footer, header, hgroup, main, nav, section, summary { display: block; } /** * Correct `inline-block` display not defined in IE 8/9. */ audio, canvas, video { display: inline-block; } /** * Prevent modern browsers from displaying `audio` without controls. * Remove excess height in iOS 5 devices. */ audio:not([controls]) { display: none; height: 0; } /** * Address `[hidden]` styling not present in IE 8/9. * Hide the `template` element in IE, Safari, and Firefox &lt; 22. */ [hidden], template { display: none; } /* ========================================================================== Base ========================================================================== */ /** * 1. Set default font family to sans-serif. * 2. Prevent iOS text size adjust after orientation change, without disabling * user zoom. */ html { font-family: sans-serif; /* 1 */ -ms-text-size-adjust: 100%; /* 2 */ -webkit-text-size-adjust: 100%; /* 2 */ } /** * Remove default margin. */ body { margin: 0; } /* ========================================================================== Links ========================================================================== */ /** * Remove the gray background color from active links in IE 10. */ a { background: transparent; } /** * Address `outline` inconsistency between Chrome and other browsers. */ a:focus { outline: thin dotted; } /** * Improve readability when focused and also mouse hovered in all browsers. */ a:active, a:hover { outline: 0; } /* ========================================================================== Typography ========================================================================== */ /** * Address variable `h1` font-size and margin within `section` and `article` * contexts in Firefox 4+, Safari 5, and Chrome. */ h1 { font-size: 2em; margin: 0.67em 0; } /** * Address styling not present in IE 8/9, Safari 5, and Chrome. */ abbr[title] { border-bottom: 1px dotted; } /** * Address style set to `bolder` in Firefox 4+, Safari 5, and Chrome. */ b, strong { font-weight: bold; } /** * Address styling not present in Safari 5 and Chrome. */ dfn { font-style: italic; } /** * Address differences between Firefox and other browsers. */ hr { -moz-box-sizing: content-box; box-sizing: content-box; height: 0; } /** * Address styling not present in IE 8/9. */ mark { background: #ff0; color: #000; } /** * Correct font family set oddly in Safari 5 and Chrome. */ code, kbd, pre, samp { font-family: monospace, serif; font-size: 1em; } /** * Improve readability of pre-formatted text in all browsers. */ pre { white-space: pre-wrap; } /** * Set consistent quote types. */ q { quotes: "\201C" "\201D" "\2018" "\2019"; } /** * Address inconsistent and variable font size in all browsers. */ small { font-size: 80%; } /** * Prevent `sub` and `sup` affecting `line-height` in all browsers. */ sub, sup { font-size: 75%; line-height: 0; position: relative; vertical-align: baseline; } sup { top: -0.5em; } sub { bottom: -0.25em; } /* ========================================================================== Embedded content ========================================================================== */ /** * Remove border when inside `a` element in IE 8/9. */ img { border: 0; } /** * Correct overflow displayed oddly in IE 9. */ svg:not(:root) { overflow: hidden; } /* ========================================================================== Figures ========================================================================== */ /** * Address margin not present in IE 8/9 and Safari 5. */ figure { margin: 0; } /* ========================================================================== Forms ========================================================================== */ /** * Define consistent border, margin, and padding. */ fieldset { border: 1px solid #c0c0c0; margin: 0 2px; padding: 0.35em 0.625em 0.75em; } /** * 1. Correct `color` not being inherited in IE 8/9. * 2. Remove padding so people aren't caught out if they zero out fieldsets. */ legend { border: 0; /* 1 */ padding: 0; /* 2 */ } /** * 1. Correct font family not being inherited in all browsers. * 2. Correct font size not being inherited in all browsers. * 3. Address margins set differently in Firefox 4+, Safari 5, and Chrome. */ button, input, select, textarea { font-family: inherit; /* 1 */ font-size: 100%; /* 2 */ margin: 0; /* 3 */ } /** * Address Firefox 4+ setting `line-height` on `input` using `!important` in * the UA stylesheet. */ button, input { line-height: normal; } /** * Address inconsistent `text-transform` inheritance for `button` and `select`. * All other form control elements do not inherit `text-transform` values. * Correct `button` style inheritance in Chrome, Safari 5+, and IE 8+. * Correct `select` style inheritance in Firefox 4+ and Opera. */ button, select { text-transform: none; } /** * 1. Avoid the WebKit bug in Android 4.0.* where (2) destroys native `audio` * and `video` controls. * 2. Correct inability to style clickable `input` types in iOS. * 3. Improve usability and consistency of cursor style between image-type * `input` and others. */ button, html input[type="button"], /* 1 */ input[type="reset"], input[type="submit"] { -webkit-appearance: button; /* 2 */ cursor: pointer; /* 3 */ } /** * Re-set default cursor for disabled elements. */ button[disabled], html input[disabled] { cursor: default; } /** * 1. Address box sizing set to `content-box` in IE 8/9/10. * 2. Remove excess padding in IE 8/9/10. */ input[type="checkbox"], input[type="radio"] { box-sizing: border-box; /* 1 */ padding: 0; /* 2 */ } /** * 1. Address `appearance` set to `searchfield` in Safari 5 and Chrome. * 2. Address `box-sizing` set to `border-box` in Safari 5 and Chrome * (include `-moz` to future-proof). */ input[type="search"] { -webkit-appearance: textfield; /* 1 */ -moz-box-sizing: content-box; -webkit-box-sizing: content-box; /* 2 */ box-sizing: content-box; } /** * Remove inner padding and search cancel button in Safari 5 and Chrome * on OS X. */ input[type="search"]::-webkit-search-cancel-button, input[type="search"]::-webkit-search-decoration { -webkit-appearance: none; } /** * Remove inner padding and border in Firefox 4+. */ button::-moz-focus-inner, input::-moz-focus-inner { border: 0; padding: 0; } /** * 1. Remove default vertical scrollbar in IE 8/9. * 2. Improve readability and alignment in all browsers. */ textarea { overflow: auto; /* 1 */ vertical-align: top; /* 2 */ } /* ========================================================================== Tables ========================================================================== */ /** * Remove most spacing between table cells. */ table { border-collapse: collapse; border-spacing: 0; } .go-top { position: fixed; bottom: 2em; right: 2em; text-decoration: none; background-color: #E0E0E0; font-size: 12px; padding: 1em; display: inline; } /* Github css */ html,body{ margin: auto; padding-right: 1em; padding-left: 1em; max-width: 44em; color:black;}*:not('#mkdbuttons'){margin:0;padding:0}body{font:13.34px helvetica,arial,freesans,clean,sans-serif;-webkit-font-smoothing:subpixel-antialiased;line-height:1.4;padding:3px;background:#fff;border-radius:3px;-moz-border-radius:3px;-webkit-border-radius:3px}p{margin:1em 0}a{color:#4183c4;text-decoration:none}body{background-color:#fff;padding:30px;margin:15px;font-size:14px;line-height:1.6}body&gt;*:first-child{margin-top:0!important}body&gt;*:last-child{margin-bottom:0!important}@media screen{body{box-shadow:0 0 0 1px #cacaca,0 0 0 4px #eee}}h1,h2,h3,h4,h5,h6{margin:20px 0 10px;padding:0;font-weight:bold;-webkit-font-smoothing:subpixel-antialiased;cursor:text}h1{font-size:28px;color:#000}h2{font-size:24px;border-bottom:1px solid #ccc;color:#000}h3{font-size:18px;color:#333}h4{font-size:16px;color:#333}h5{font-size:14px;color:#333}h6{color:#777;font-size:14px}p,blockquote,table,pre{margin:15px 0}ul{padding-left:30px}ol{padding-left:30px}ol li ul:first-of-type{margin-top:0}hr{background:transparent url(data:image/png;base64,iVBORw0KGgoAAAANSUhEUgAAAAYAAAAECAYAAACtBE5DAAAAGXRFWHRTb2Z0d2FyZQBBZG9iZSBJbWFnZVJlYWR5ccllPAAAAyJpVFh0WE1MOmNvbS5hZG9iZS54bXAAAAAAADw/eHBhY2tldCBiZWdpbj0i77u/IiBpZD0iVzVNME1wQ2VoaUh6cmVTek5UY3prYzlkIj8+IDx4OnhtcG1ldGEgeG1sbnM6eD0iYWRvYmU6bnM6bWV0YS8iIHg6eG1wdGs9IkFkb2JlIFhNUCBDb3JlIDUuMC1jMDYwIDYxLjEzNDc3NywgMjAxMC8wMi8xMi0xNzozMjowMCAgICAgICAgIj4gPHJkZjpSREYgeG1sbnM6cmRmPSJodHRwOi8vd3d3LnczLm9yZy8xOTk5LzAyLzIyLXJkZi1zeW50YXgtbnMjIj4gPHJkZjpEZXNjcmlwdGlvbiByZGY6YWJvdXQ9IiIgeG1sbnM6eG1wPSJodHRwOi8vbnMuYWRvYmUuY29tL3hhcC8xLjAvIiB4bWxuczp4bXBNTT0iaHR0cDovL25zLmFkb2JlLmNvbS94YXAvMS4wL21tLyIgeG1sbnM6c3RSZWY9Imh0dHA6Ly9ucy5hZG9iZS5jb20veGFwLzEuMC9zVHlwZS9SZXNvdXJjZVJlZiMiIHhtcDpDcmVhdG9yVG9vbD0iQWRvYmUgUGhvdG9zaG9wIENTNSBNYWNpbnRvc2giIHhtcE1NOkluc3RhbmNlSUQ9InhtcC5paWQ6OENDRjNBN0E2NTZBMTFFMEI3QjRBODM4NzJDMjlGNDgiIHhtcE1NOkRvY3VtZW50SUQ9InhtcC5kaWQ6OENDRjNBN0I2NTZBMTFFMEI3QjRBODM4NzJDMjlGNDgiPiA8eG1wTU06RGVyaXZlZEZyb20gc3RSZWY6aW5zdGFuY2VJRD0ieG1wLmlpZDo4Q0NGM0E3ODY1NkExMUUwQjdCNEE4Mzg3MkMyOUY0OCIgc3RSZWY6ZG9jdW1lbnRJRD0ieG1wLmRpZDo4Q0NGM0E3OTY1NkExMUUwQjdCNEE4Mzg3MkMyOUY0OCIvPiA8L3JkZjpEZXNjcmlwdGlvbj4gPC9yZGY6UkRGPiA8L3g6eG1wbWV0YT4gPD94cGFja2V0IGVuZD0iciI/PqqezsUAAAAfSURBVHjaYmRABcYwBiM2QSA4y4hNEKYDQxAEAAIMAHNGAzhkPOlYAAAAAElFTkSuQmCC) repeat-x 0 0;border:0 none;color:#ccc;height:4px;padding:0}body&gt;h2:first-child{margin-top:0;padding-top:0}body&gt;h1:first-child{margin-top:0;padding-top:0}body&gt;h1:first-child+h2{margin-top:0;padding-top:0}body&gt;h3:first-child,body&gt;h4:first-child,body&gt;h5:first-child,body&gt;h6:first-child{margin-top:0;padding-top:0}a:first-child h1,a:first-child h2,a:first-child h3,a:first-child h4,a:first-child h5,a:first-child h6{margin-top:0;padding-top:0}h1+p,h2+p,h3+p,h4+p,h5+p,h6+p,ul li&gt;:first-child,ol li&gt;:first-child{margin-top:0}dl{padding:0}dl dt{font-size:14px;font-weight:bold;font-style:italic;padding:0;margin:15px 0 5px}dl dt:first-child{padding:0}dl dt&gt;:first-child{margin-top:0}dl dt&gt;:last-child{margin-bottom:0}dl dd{margin:0 0 15px;padding:0 15px}dl dd&gt;:first-child{margin-top:0}dl dd&gt;:last-child{margin-bottom:0}blockquote{border-left:4px solid #DDD;padding:0 15px;color:#777}blockquote&gt;:first-child{margin-top:0}blockquote&gt;:last-child{margin-bottom:0}table{border-collapse:collapse;border-spacing:0;font-size:100%;font:inherit}table th{font-weight:bold;border:1px solid #ccc;padding:6px 13px}table td{border:1px solid #ccc;padding:6px 13px}table tr{border-top:1px solid #ccc;background-color:#fff}table tr:nth-child(2n){background-color:#f8f8f8}img{max-width:100%}code,tt{margin:0 2px;padding:0 5px;white-space:nowrap;border:1px solid #eaeaea;background-color:#f8f8f8;border-radius:3px;font-family:Consolas,'Liberation Mono',Courier,monospace;font-size:12px;color:#333}pre&gt;code{margin:0;padding:0;white-space:pre;border:0;background:transparent}.highlight pre{background-color:#f8f8f8;border:1px solid #ccc;font-size:13px;line-height:19px;overflow:auto;padding:6px 10px;border-radius:3px}pre{background-color:#f8f8f8;border:1px solid #ccc;font-size:13px;line-height:19px;overflow:auto;padding:6px 10px;border-radius:3px}pre code,pre tt{background-color:transparent;border:0}.poetry pre{font-family:Georgia,Garamond,serif!important;font-style:italic;font-size:110%!important;line-height:1.6em;display:block;margin-left:1em}.poetry pre code{font-family:Georgia,Garamond,serif!important;word-break:break-all;word-break:break-word;-webkit-hyphens:auto;-moz-hyphens:auto;hyphens:auto;white-space:pre-wrap}sup,sub,a.footnote{font-size:1.4ex;height:0;line-height:1;vertical-align:super;position:relative}sub{vertical-align:sub;top:-1px}@media print{body{background:#fff}img,pre,blockquote,table,figure{page-break-inside:avoid}body{background:#fff;border:0}code{background-color:#fff;color:#333!important;padding:0 .2em;border:1px solid #dedede}pre{background:#fff}pre code{background-color:white!important;overflow:visible}}@media screen{body.inverted{color:#eee!important;border-color:#555;box-shadow:none}.inverted body,.inverted hr .inverted p,.inverted td,.inverted li,.inverted h1,.inverted h2,.inverted h3,.inverted h4,.inverted h5,.inverted h6,.inverted th,.inverted .math,.inverted caption,.inverted dd,.inverted dt,.inverted blockquote{color:#eee!important;border-color:#555;box-shadow:none}.inverted td,.inverted th{background:#333}.inverted h2{border-color:#555}.inverted hr{border-color:#777;border-width:1px!important}::selection{background:rgba(157,193,200,0.5)}h1::selection{background-color:rgba(45,156,208,0.3)}h2::selection{background-color:rgba(90,182,224,0.3)}h3::selection,h4::selection,h5::selection,h6::selection,li::selection,ol::selection{background-color:rgba(133,201,232,0.3)}code::selection{background-color:rgba(0,0,0,0.7);color:#eee}code span::selection{background-color:rgba(0,0,0,0.7)!important;color:#eee!important}a::selection{background-color:rgba(255,230,102,0.2)}.inverted a::selection{background-color:rgba(255,230,102,0.6)}td::selection,th::selection,caption::selection{background-color:rgba(180,237,95,0.5)}.inverted{background:#0b2531;background:#252a2a}.inverted body{background:#252a2a}.inverted a{color:#acd1d5}}.highlight .c{color:#998;font-style:italic}.highlight .err{color:#a61717;background-color:#e3d2d2}.highlight .k,.highlight .o{font-weight:bold}.highlight .cm{color:#998;font-style:italic}.highlight .cp{color:#999;font-weight:bold}.highlight .c1{color:#998;font-style:italic}.highlight .cs{color:#999;font-weight:bold;font-style:italic}.highlight .gd{color:#000;background-color:#fdd}.highlight .gd .x{color:#000;background-color:#faa}.highlight .ge{font-style:italic}.highlight .gr{color:#a00}.highlight .gh{color:#999}.highlight .gi{color:#000;background-color:#dfd}.highlight .gi .x{color:#000;background-color:#afa}.highlight .go{color:#888}.highlight .gp{color:#555}.highlight .gs{font-weight:bold}.highlight .gu{color:#800080;font-weight:bold}.highlight .gt{color:#a00}.highlight .kc,.highlight .kd,.highlight .kn,.highlight .kp,.highlight .kr{font-weight:bold}.highlight .kt{color:#458;font-weight:bold}.highlight .m{color:#099}.highlight .s{color:#d14}.highlight .na{color:#008080}.highlight .nb{color:#0086b3}.highlight .nc{color:#458;font-weight:bold}.highlight .no{color:#008080}.highlight .ni{color:#800080}.highlight .ne,.highlight .nf{color:#900;font-weight:bold}.highlight .nn{color:#555}.highlight .nt{color:#000080}.highlight .nv{color:#008080}.highlight .ow{font-weight:bold}.highlight .w{color:#bbb}.highlight .mf,.highlight .mh,.highlight .mi,.highlight .mo{color:#099}.highlight .sb,.highlight .sc,.highlight .sd,.highlight .s2,.highlight .se,.highlight .sh,.highlight .si,.highlight .sx{color:#d14}.highlight .sr{color:#009926}.highlight .s1{color:#d14}.highlight .ss{color:#990073}.highlight .bp{color:#999}.highlight .vc,.highlight .vg,.highlight .vi{color:#008080}.highlight .il{color:#099}.highlight .gc{color:#999;background-color:#eaf2f5}.type-csharp .highlight .k,.type-csharp .highlight .kt{color:#00F}.type-csharp .highlight .nf{color:#000;font-weight:normal}.type-csharp .highlight .nc{color:#2b91af}.type-csharp .highlight .nn{color:#000}.type-csharp .highlight .s,.type-csharp .highlight .sc{color:#a31515}&nbsp;</p>
